R oS5 510(k) Summary 1.0 Submitted By:

First Page		Document Content
Date: 2011-02-17 14:36:01 Immunoassay Phospholipase A2 Lipoprotein-associated phospholipase A2 ELISA Medical device Cardiovascular disease Lipoprotein Premarket approval Atherosclerosis Medicine Immunologic tests Peripheral membrane proteins		R oS5 510(k) Summary 1.0 Submitted By: Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 169,53 KB Share Document on Facebook

	Leading Technology in Fluid-Stable Reagents from DiaSys • Global player in clinical chemistry tests with recognized R & D department • Quality products made in Germany • High quality raw materials from traceable DocID: 1gGaF - View Document
	An enzymatic Lp-PLA2 assay for fully automated analysis: A valuable supplementation to currently used cardiovascular risk assessment Alexandra Lein, Irene Delseith, Thomas Hektor, Michael Marcus Hoffmann, Karl Winkler, M DocID: 1frSB - View Document
	Lp-PLA 2 Lipoprotein-associated phospholipase A 2 Emerging Biomarker in Atherosclerotic Risk Assessment Determination DocID: 1aLUp - View Document
	BioSys/BioISI Research Seminar Why and how cells regulate their volume Karl Kunzelmann University of Regensburg, Germany DocID: 13VDQ - View Document
	Developmental changes in human dopamine neurotransmission: cortical receptors and terminators DocID: 131P0 - View Document